These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26701364)

  • 1. The effects of sequential use of oxytocin and sublingual nitroglycerin in the cases of retained placenta.
    Kashanian M; Hasankhani S; Sheikhansari N; Bahasadri S; Homam H
    J Matern Fetal Neonatal Med; 2016 Oct; 29(20):3254-9. PubMed ID: 26701364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublingual nitroglycerin for management of retained placenta.
    Bullarbo M; Tjugum J; Ekerhovd E
    Int J Gynaecol Obstet; 2005 Dec; 91(3):228-32. PubMed ID: 16226759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocolysis for management of retained placenta.
    Abdel-Aleem H; Abdel-Aleem MA; Shaaban OM
    Cochrane Database Syst Rev; 2011 Jan; (1):CD007708. PubMed ID: 21249693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublingual nitroglycerin seems to be effective in the management of retained placenta.
    Ekerhovd E; Bullarbo M
    Acta Obstet Gynecol Scand; 2008; 87(2):222-5. PubMed ID: 18231892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glyceryl trinitrate to reduce the need for manual removal of retained placenta following vaginal delivery: the GOT-IT RCT.
    Denison FC; Carruthers KF; Hudson J; McPherson G; Scotland G; Brook-Smith S; Clarkson C; Peace M; Brewin J; Chua GN; Hallowell N; Norman JE; Lawton J; Norrie J
    Health Technol Assess; 2019 Dec; 23(70):1-72. PubMed ID: 31912780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The retained placenta.
    Weeks AD
    Best Pract Res Clin Obstet Gynaecol; 2008 Dec; 22(6):1103-17. PubMed ID: 18793876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different routes and forms of uterotonics for treatment of retained placenta: a randomized clinical trial.
    Maher MA; Sayyed TM; Elkhouly NI
    J Matern Fetal Neonatal Med; 2017 Sep; 30(18):2179-2184. PubMed ID: 27677547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitroglycerin for treatment of retained placenta: A randomised, placebo-controlled, multicentre, double-blind trial in the UK.
    Denison FC; Carruthers KF; Hudson J; McPherson G; Chua GN; Peace M; Brewin J; Hallowell N; Scotland G; Lawton J; Norrie J; Norman JE;
    PLoS Med; 2019 Dec; 16(12):e1003001. PubMed ID: 31887169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous nitroglycerin for controlled cord traction in the management of retained placenta.
    Visalyaputra S; Prechapanich J; Suwanvichai S; Yimyam S; Permpolprasert L; Suksopee P
    Int J Gynaecol Obstet; 2011 Feb; 112(2):103-6. PubMed ID: 21144515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraumbilical injection of uterotonics for retained placenta.
    Habek D; Franicević D
    Int J Gynaecol Obstet; 2007 Nov; 99(2):105-9. PubMed ID: 17603061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intraumbilical vein oxytocin injection on third stage of labor.
    Nankali A; Keshavarzi F; Fakheri T; Zare S; Rezaei M; Daeichin S
    Taiwan J Obstet Gynecol; 2013 Mar; 52(1):57-60. PubMed ID: 23548219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Release Trial: a randomised controlled trial of umbilical vein oxytocin versus placebo for the treatment of retained placenta.
    Weeks A; Mirembe F; Alfirevic Z
    BJOG; 2005 Oct; 112(10):1458. PubMed ID: 16167963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbetocin versus intra-umbilical oxytocin in the management of retained placenta: a randomized clinical study.
    Elfayomy AK
    J Obstet Gynaecol Res; 2015 Aug; 41(8):1207-13. PubMed ID: 25976063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pragmatic group sequential, placebo-controlled, randomised trial to determine the effectiveness of glyceryl trinitrate for retained placenta (GOT-IT): a study protocol.
    Denison FC; Norrie J; Lawton J; Norman JE; Scotland G; McPherson GC; McDonald A; Forrest M; Hudson J; Brewin J; Peace M; Clarkson C; Brook-Smith S; Morrow S; Hallowell N; Hodges L; Carruthers KF
    BMJ Open; 2017 Sep; 7(9):e017134. PubMed ID: 28928192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraumbilical injection of three different uterotonics in the management of retained placenta.
    Harara R; Hanafy S; Zidan MS; Alberry M
    J Obstet Gynaecol Res; 2011 Sep; 37(9):1203-7. PubMed ID: 21518127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage.
    Jackson KW; Allbert JR; Schemmer GK; Elliot M; Humphrey A; Taylor J
    Am J Obstet Gynecol; 2001 Oct; 185(4):873-7. PubMed ID: 11641669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic intervention for the management of retained placenta: a systematic review and meta-analysis of randomized trials.
    Patrick HS; Mitra A; Rosen T; Ananth CV; Schuster M
    Am J Obstet Gynecol; 2020 Sep; 223(3):447.e1-447.e19. PubMed ID: 32592695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraumbilical veinous injection oxytocin in the active management of third stage of labour.
    Tehseen F; Anwar A; Arfat Y
    J Coll Physicians Surg Pak; 2008 Sep; 18(9):551-4. PubMed ID: 18803892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the optimal pharmacological management of retained placenta?
    Duffy JM; Wilson MJ; Khan KS
    BMJ; 2014 Jul; 349():g4778. PubMed ID: 25069774
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of intra-umbilical oxytocin in the management of retained placenta: a randomized controlled trial.
    Samanta A; Roy SG; Mistri PK; Mitra A; Pal R; Naskar A; Bhattacharya SK; Pal PP; Pande A
    J Obstet Gynaecol Res; 2013 Jan; 39(1):75-82. PubMed ID: 22889466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.